C5aR1 is shown as a potential therapeutic target modulating actin rearrangement and thereby metastasis (124), while the studies on C5aR2 in cancer have yielded conflicting results, highlighting its complex role in various malignancies. The gene discussed is C5AR1; the disease is cancer.